Clinical trial

Opicapone Treatment Initiation Open-Label Study

NCT04787965

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2021-03-01

PhaseN/A

Study timeline

Study start (actual)2021-03-01Date precision: day

Registry last updated2022-11-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

OpicaponeDRUG · verified · RxNorm: opicapone

Sponsors & collaborators

Neurocrine Bioscienceslead sponsor

Mapped research locations

MemphisTennessee, United States1 NorfolkVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04787965 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.